In addition, DCHD-SV modulates the intestinal flora and liver metabolites of T2DM mice, and may exert its anti-diabetic effects through the PPARγ/AMPK/mTOR signaling pathway. This evidence concerns the gene MTOR and type 2 diabetes mellitus.